News about Global Pharma

Suven Pharmaceuticals Rebranded as Cohance Lifesciences

Suven Pharmaceuticals has renamed the company as Cohance Lifesciences with the objective to have a better reach worldwide.

Global Pharma | 08/05/2025 | By Manvi |  1207

Celerion Introduces Enhanced Version of Labnotes Bioanalytical Data Management Software

Celerion has launched an enhanced version of Labnotes, its electronic laboratory notebook software, introducing advanced data management, security, and reporting features to improve operational efficiency and support sponsor success.

Global Pharma | 08/05/2025 | By Manvi |  248

US FDA Appoints Dr. Vinay Prasad to Lead Biologics, Vaccines Division

US FDA selects Dr. Vinay Prasad as the head of the vaccine division of Biologics. The FDA expressed hope that his presence would bring more scrutiny and requirements to developers creating new gene therapies.

Global Pharma | 08/05/2025 | By Manvi |  307

US President Announces High Tariff Rates on Pharmaceutical Imports

America proposes high tariffs on pharmaceutical imports to boost domestic manufacturers.

Global Pharma | 08/05/2025 | By Manvi |  323

Gates Foundation Gives USD 2.5 Million Grant to Evotec for Advancement of TB Treatment

Evotec will utilise the USD 2.5 million grants awarded by the Gates Foundation for the future development of drugs to treat tuberculosis.

Global Pharma | 08/05/2025 | By Manvi |  399

Lupin Launches Eslicarbazepine Acetate Tablets in the United States

Lupin has launched its US FDA-approved generic Eslicarbazepine Acetate Tablets in 200 mg, 400 mg, 600 mg, and 800 mg strengths in the US.

Global Pharma | 07/05/2025 | By Manvi |  243

SK bioscience Chosen for KDCA's Pandemic Preparedness R&D Program

SK bioscience announced that it has been selected for the Korea Disease Control and Prevention Agency (KDCA)'s Priority Infectious Disease Pandemic Preparedness Rapid R&D Support Program.

Global Pharma | 07/05/2025 | By Manvi |  158

AliveCor Launches AI-Powered KardiaMobile 6L Max with Smart Heart Alerts

With KardiaMobile 6L Max and KardiaAlert, users gain access to technology and tools that offer more detections and insights, monitor heart rhythm for potential changes over time, and alert patients–helping them take action.

Global Pharma | 07/05/2025 | By Manvi |  259

Gautam Shah Takes Over as President US Operations of Senores Pharmaceuticals

US subsidiary of Senores Pharmaceuticals, Havix Group Inc. D/B/A Aavis Pharmaceuticals, with the appointment of Gautam Shah as President of US Operations plans to scale new heights and expand their business

Global Pharma | 07/05/2025 | By Manvi |  229

IDEAYA Biosciences Secures US FDA IND-Clearance for IDE849

IDEAYA Biosciences has received FDA clearance to initiate a Phase 1 trial of IDE849, a potential first-in-class DLL3-targeting antibody-drug conjugate for advanced solid tumours, including small cell lung cancer.

Global Pharma | 06/05/2025 | By Manvi |  314